Evidence map›Paper›PMID 39677727›Full record

ArticlebioRxiv : the preprint server for biology2024

Retromer Opposes Opioid-Induced Downregulation of the Mu Opioid Receptor.

Aleksandra Dagunts, Hayden Adoff, Brandon Novy, Monica De Maria, Braden T Lobingier

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Aleksandra DaguntsDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0001-9378-8017
Hayden AdoffDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0002-0373-3678
Brandon NovyDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0001-5304-2640
Monica De MariaDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.
Braden T LobingierDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0001-7881-7502

Funding

Medical Scientist Training Program of Oregon Health & Science UniversityT32GM141938 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI CHEN, YABING · 2021 to 2025
$4.6M
Program in Biomedical SciencesT32GM142619 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jeffrey Wallace Tyner · 2021 to 2026
$3.2M
Endosomes as a multifunctional hub to control GPCR functionR35GM137835 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Braden Lobingier · 2020 to 2026
$2.5M
NIGMS NIH HHS R35 GM137835NIGMS NIH HHS T32 GM141938NIGMS NIH HHS T32 GM142619
6 · The paper itself

Abstract

The mu opioid receptor (MOR) is protected from opioid-induced trafficking to lysosomes and proteolytic downregulation by its ability to access the endosomal recycling pathway through its C-terminal recycling motif, LENL. MOR sorting towards the lysosome results in downregulation of opioid signaling while recycling of MOR to the plasma membrane preserves signaling function. However, the mechanisms by which LENL promotes MOR recycling are unknown, and this sequence does not match any known consensus recycling motif. Here we took a functional genomics approach with a comparative genome-wide screen design to identify genes which control opioid receptor expression and downregulation. We identified 146 hits including all three subunits of the endosomal Retromer complex. We show that the LENL motif in MOR is a novel Retromer recycling motif and that LENL is a necessary, sufficient, and conserved mechanism to give MOR access to the Retromer recycling pathway and protect MOR from agonist-induced downregulation to multiple clinically relevant opioids including fentanyl and methadone.

Identifiers

PMID39677727
PMCPMC11642924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.